CA
TGTX icon

Cetera Advisors’s TG Therapeutics TGTX Stock Holding History

Cetera Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$622K Buy
+40,900
New +$652K ﹤0.01% 1456

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cetera Advisors's TGTX Position: Q1 2024 in Review

Cetera Advisors opened a new position in TG Therapeutics (TGTX) in Q1 2024: 40,900 shares worth $622K. The stake represents ﹤0.01% of the portfolio and ranks #1456 among its holdings.

243 funds tracked by Wall St. Rank hold TGTX as of Q1 2024.

  • Cetera Advisors held 40,900 shares of TG Therapeutics worth $622K as of Q1 2024.
  • TG Therapeutics was a new Cetera Advisors position in Q1 2024.
  • TG Therapeutics made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1456 holding.
  • 243 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.